← Leaderboards
Richard P Schwarz
Kardia Therapeutics, Inc.
$2,684,254
Attributed
$2,684,254
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $734.6K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$2,684,254 · 3
By mechanism
R42$2,058,608 · 1
R41$625,646 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Heart Failure”
- Judith S Hochman · New York University School Of Medicine$120,321,606
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Walter N Kernan · Yale University$42,197,025
- Dalane W Kitzman · Wake Forest University$40,701,149
- David Couper · Univ Of North Carolina Chapel Hill$37,959,091
Research focus
Heart FailureAccountingAwardCollaborationsAntigensAdultAdult Stem CellAcute Myocardial InfarctionBiologicalAnimalsBlood VesselsBone MarrowAutologousCardiacClinical TrialsCardiogenesisBaseCell Differentiation ProcessCellsCell TypeChronicBiotechnologyClinical DataCollege
Grant awards (5)
ADULT HUMAN PROGENITOR CELLS FOR CARDIAC REGENERATION$659,436
R42 · FY2011 · HL · contact PI
ADULT HUMAN PROGENITOR CELLS FOR CARDIAC REGENERATION$664,605
R42 · FY2008 · HL · contact PI
ADULT HUMAN PROGENITOR CELLS FOR CARDIAC REGENERATION$734,567
R42 · FY2007 · HL · contact PI
ADULT HUMAN PROGENITOR CELLS FOR CARDIAC REGENERATION$525,646
R41 · FY2005 · HL
GHRH TREATMENT OF HEART FAILURE$100,000
R41 · FY2004 · HL